Kodiak (KOD) is a clinical phase biotech focused on retinal diseases, with a compact, but promising late-stage pipeline. The company currently has three molecules in late stage clinical trials, ...

London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as ...

Your browser does not support the audio element. CSS Grid is a new way of creating layouts on the web. For the first time ever we have a proper layout system ...

Adam Hayes, Ph.D., CFA, is a financial writer with 15+ years Wall Street experience as a derivatives trader. Besides his extensive derivative trading expertise, Adam is an expert in economics and ...

Kodal Minerals Plc is a mineral exploration and development company, which engages in the exploration and development of mineral assets. It operates through the following segments: West African Gold ...

The 2025 KOD World Street Dance Championship is making an anticipated return to Beijing next month. [Photo provided to chinadaily.com.cn] With some jaw-dropping moves to electrifying beats guaranteed, ...

President of the Republic of Ghana, John Dramani Mahama, has appointed media personality and creative entrepreneur, Kofi Okyere-Darko (KOD) as Director of Diaspora Affairs. KOD confirmed the ...

Kodiak Sciences basically uses a novel biopolymer conjugate platform to develop more durable, next-generation retinal disease therapies. Today, KOD’s pipeline includes Phase 3 candidates for DR, RVO, ...

Shares of Kodiak Sciences KOD rallied 29.6% on Monday after an eminent financial services company, Jefferies, upgraded KOD to a “BUY” rating stating that the company has a major “turnaround story” in ...